Philadelphia Trust Company’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $513K | Sell |
3,684
-962
| -21% | -$135K | 0.04% | 158 |
|
|
2025
Q4 | $570K | Buy |
4,646
+2,456
| +112% | +$298K | 0.04% | 150 |
|
|
2025
Q3 | $243K | Buy |
+2,190
| New | +$249K | 0.02% | 224 |
|
|
2025
Q1 | – | Sell |
-85,437
| Closed | -$7.89M | – | 248 |
|
|
2024
Q4 | $7.89M | Sell |
85,437
-745
| -0.9% | -$67.1K | 0.58% | 44 |
|
|
2024
Q3 | $7.22M | Buy |
86,182
+9,565
| +12% | +$730K | 0.52% | 48 |
|
|
2024
Q2 | $5.26M | Sell |
76,617
-6,673
| -8% | -$445K | 0.41% | 57 |
|
|
2024
Q1 | $6.1M | Sell |
83,290
-551
| -0.7% | -$42.4K | 0.49% | 55 |
|
|
2023
Q4 | $6.79M | Sell |
83,841
-1,400
| -2% | -$109K | 0.64% | 49 |
|
|
2023
Q3 | $6.39M | Buy |
85,241
+831
| +1% | +$63.9K | 0.66% | 48 |
|
|
2023
Q2 | $6.5M | Sell |
84,410
-2,485
| -3% | -$198K | 0.62% | 50 |
|
|
2023
Q1 | $7.21M | Sell |
86,895
-5,225
| -6% | -$433K | 0.73% | 39 |
|
|
2022
Q4 | $7.91M | Sell |
92,120
-13,210
| -13% | -$1.05M | 0.85% | 29 |
|
|
2022
Q3 | $6.5M | Sell |
105,330
-5,775
| -5% | -$364K | 0.73% | 37 |
|
|
2022
Q2 | $6.87M | Sell |
111,105
-755
| -0.7% | -$46.7K | 0.71% | 39 |
|
|
2022
Q1 | $6.65M | Buy |
111,860
+45,845
| +69% | +$2.93M | 0.52% | 50 |
|
|
2021
Q4 | $4.79M | Buy |
66,015
+915
| +1% | +$63K | 0.35% | 60 |
|
|
2021
Q3 | $4.55M | Buy |
65,100
+50,050
| +333% | +$3.52M | 0.34% | 63 |
|
|
2021
Q2 | $1.04M | Sell |
15,050
-1,463
| -9% | -$97.7K | 0.07% | 132 |
|
|
2021
Q1 | $1.07M | Sell |
16,513
-110
| -0.7% | -$7.09K | 0.08% | 129 |
|
|
2020
Q4 | $968K | Buy |
16,623
+42
| +0.3% | +$2.53K | 0.08% | 121 |
|
|
2020
Q3 | $1.05M | Sell |
16,581
-433
| -3% | -$30K | 0.1% | 107 |
|
|
2020
Q2 | $1.31M | Buy |
17,014
+262
| +2% | +$20.1K | 0.14% | 89 |
|
|
2020
Q1 | $1.25M | Sell |
16,752
-2,310
| -12% | -$160K | 0.16% | 79 |
|
|
2019
Q4 | $1.24M | Sell |
19,062
-3,355
| -15% | -$218K | 0.11% | 103 |
|
|
2019
Q3 | $1.42M | Sell |
22,417
-2,125
| -9% | -$139K | 0.13% | 98 |
|
|
2019
Q2 | $1.66M | Sell |
24,542
-630
| -3% | -$41.4K | 0.15% | 102 |
|
|
2019
Q1 | $1.64M | Buy |
25,172
+1,262
| +5% | +$83.9K | 0.14% | 92 |
|
|
2018
Q4 | $1.5M | Buy |
23,910
+175
| +0.7% | +$12.2K | 0.16% | 88 |
|
|
2018
Q3 | $1.83M | Buy |
23,735
+220
| +0.9% | +$16.6K | 0.15% | 91 |
|
|
2018
Q2 | $1.67M | Sell |
23,515
-1,320
| -5% | -$93.2K | 0.15% | 90 |
|
|
2018
Q1 | $1.87M | Buy |
24,835
+2,855
| +13% | +$227K | 0.16% | 93 |
|
|
2017
Q4 | $1.57M | Buy |
21,980
+2,709
| +14% | +$206K | 0.12% | 104 |
|
|
2017
Q3 | $1.56M | Buy |
19,271
+3,081
| +19% | +$236K | 0.13% | 105 |
|
|
2017
Q2 | $1.15M | Buy |
16,190
+1,652
| +11% | +$110K | 0.1% | 115 |
|
|
2017
Q1 | $987K | Buy |
14,538
+240
| +2% | +$16.9K | 0.08% | 122 |
|
|
2016
Q4 | $1.02M | Sell |
14,298
-1,533
| -10% | -$114K | 0.08% | 126 |
|
|
2016
Q3 | $1.25M | Buy |
15,831
+670
| +4% | +$54.4K | 0.11% | 109 |
|
|
2016
Q2 | $1.26M | Sell |
15,161
-5,235
| -26% | -$465K | 0.11% | 108 |
|
|
2016
Q1 | $1.87M | Buy |
20,396
+5,248
| +35% | +$473K | 0.16% | 79 |
|
|
2015
Q4 | $1.6M | Sell |
15,148
-13,560
| -47% | -$1.41M | 0.13% | 87 |
|
|
2015
Q3 | $2.82M | Buy |
28,708
+17,537
| +157% | +$1.95M | 0.25% | 69 |
|
|
2015
Q2 | $95.4K | Sell |
11,171
-173,906
| -94% | -$19M | 0.35% | 69 |
|
|
2015
Q1 | $18.2M | Buy |
185,077
+48,985
| +36% | +$4.97M | 1.38% | 30 |
|
|
2014
Q4 | $12.8M | Sell |
136,092
-43,425
| -24% | -$4.49M | 1.03% | 39 |
|
|
2014
Q3 | $19.1M | Sell |
179,517
-26,378
| -13% | -$2.58M | 1.19% | 42 |
|
|
2014
Q2 | $17.1M | Buy |
205,895
+195,645
| +1,909% | +$15.2M | 1.06% | 42 |
|
|
2014
Q1 | $726K | Buy |
+10,250
| New | +$804K | 0.05% | 118 |
|
Other funds holding GILD
VCM
VPM
Philadelphia Trust Company's GILD Position: Q1 2026 in Review
Philadelphia Trust Company reduced its Gilead Sciences (GILD) stake by 21% in Q1 2026, selling an estimated $135K and leaving 3,684 shares worth $513K. The position accounts for 0.04% of the portfolio, ranked #158.
Philadelphia Trust Company first reported a position in GILD in Q1 2014 and has held it in 47 quarters since. The position peaked at $19.1M in Q3 2014. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Philadelphia Trust Company held 3,684 shares of Gilead Sciences worth $513K as of Q1 2026.
- Philadelphia Trust Company sold 962 Gilead Sciences shares in Q1 2026, an estimated $135K.
- Gilead Sciences made up 0.04% of Philadelphia Trust Company's portfolio in Q1 2026, its #158 holding.
- Philadelphia Trust Company first reported a position in Gilead Sciences in Q1 2014 and has held it in 47 quarters since.
- Philadelphia Trust Company's Gilead Sciences position peaked at $19.1M in Q3 2014.
- 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Philadelphia Trust Company's 13F filing for Q1 2026, filed 13 May 2026.